Hydrogenics (HYGS) PT Raised to $9.50 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HYGS Hot Sheet
Price: $15.00 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Join SI Premium – FREE
Canaccord Genuity analyst Raveel Afzaal raised the price target on Hydrogenics (NASDAQ: HYGS) to $9.50 (from $8.75) while maintaining a Spec. Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Annovis Bio launches public offering to fund Alzheimer's, Parkinson's trials
- Smith & Nephew PLC. (SN:LN) (SNN) PT Raised to GBP12.10 at UBS
- Scout24 (G24:GR) (SCOTF) PT Raised to EUR117 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
